21 May 2013
Keywords: vectura, year-to-march, income, soars, uk, company, focused
Article | 05 June 2006
Vectura, a UK company focused on the development of inhaled drug formulations, says that its revenue for the 12 months ended ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 June 2006
20 May 2013
© 2013 thepharmaletter.com